Product Information
ERGOMAR 2 MG TABLET SUBLINGUAL is a brand (anda) product labeled by Pangea Pharmaceuticals LLC, priced at $43.1572 per EA under NDC 81279010420. Its NADAC has been published 57 times since Jul 23, 2025.
FDA first approved this application on Feb 24, 1983.
Strength
2 mg/1
Manufacturer
Pangea Pharmaceuticals LLCNDC
81279010420
Classification
Brand (ANDA)
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ERGOTAMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA087693FDA Approved
2/24/1983
On Market Since
2/3/2025
Pharmacological Classes
Price Statistics
The NADAC for ERGOMAR 2 MG TABLET SUBLINGUAL has been published 57 times since Jul 23, 2025, and over the history we have for it it has risen 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $43.1572 per EA |
|---|---|
| All-time high | $43.1572 (Aug 19, 2026) |
| All-time low | $41.3247 (Mar 18, 2026) |
| 52-week high | $43.1572 |
| 52-week low | $41.3247 |
| Median price | $41.8900 |
| Average price | $41.9635 |
| Largest weekly change | +3.4% (May 20, 2026) |
| Weeks tracked | 57 |
| Tracking since | Jul 23, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ergotamine Tartrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ERGOMAR 2 MG TABLET SUBLINGUAL?
The current National Average Drug Acquisition Cost (NADAC) for ERGOMAR 2 MG TABLET SUBLINGUAL, manufactured by Pangea Pharmaceuticals LLC, is $43.1572 per EA (NDC 81279010420), effective Aug 19, 2026.
How has the price of ERGOMAR 2 MG TABLET SUBLINGUAL changed over time?
Over the history we have for it, the NADAC for ERGOMAR 2 MG TABLET SUBLINGUAL has risen 3.0%. It has been tracked across 57 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for ERGOMAR 2 MG TABLET SUBLINGUAL?
Since Jul 23, 2025, the NADAC for ERGOMAR 2 MG TABLET SUBLINGUAL has ranged from a low of $41.3247 (Mar 18, 2026) to a high of $43.1572 (Aug 19, 2026), with a median of $41.8900 per EA.
Are there cheaper alternatives to ERGOMAR 2 MG TABLET SUBLINGUAL?
No other NADAC-published product currently shares the active ingredient and strength of ERGOMAR 2 MG TABLET SUBLINGUAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ERGOMAR 2 MG TABLET SUBLINGUAL?
ERGOMAR 2 MG TABLET SUBLINGUAL (NDC 81279010420) is labeled by Pangea Pharmaceuticals LLC, and CMS classifies it as a brand (anda) product.